Use of denosumab in castration sensitive prostate cancer

被引:1
作者
Laurent, Michael R. [1 ]
机构
[1] Imelda Hosp, Bonheiden, Belgium
来源
BMJ-BRITISH MEDICAL JOURNAL | 2023年 / 383卷
关键词
D O I
10.1136/bmj.p2827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 4 条
[1]   The Current Practice of Screening, Prevention, and Treatment of Androgen-Deprivation-Therapy Induced Osteoporosis in Patients with Prostate Cancer [J].
Al-Shamsi, Humaid O. ;
Lau, Arthur N. ;
Malik, Kartika ;
Alamri, Abdulaziz ;
Ioannidis, George ;
Corbett, Tom ;
Adachi, J. D. ;
Papaioannou, Alexandra .
JOURNAL OF ONCOLOGY, 2012, 2012
[2]   Bone health management in men undergoing ADT: examining enablers and barriers to care [J].
Damji, A. N. ;
Bies, K. ;
Alibhai, S. M. H. ;
Jones, J. M. .
OSTEOPOROSIS INTERNATIONAL, 2015, 26 (03) :951-959
[3]   Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study [J].
Mitchell, Aaron P. ;
Dusetzina, Stacie B. ;
Meza, Akriti Mishra ;
Trivedi, Niti U. ;
Bach, Peter B. ;
Winn, Aaron .
BMJ-BRITISH MEDICAL JOURNAL, 2023, 383
[4]   Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline [J].
Shapiro, Charles L. ;
Van Poznak, Catherine ;
Lacchetti, Christina ;
Kirshner, Jeffrey ;
Eastell, Richard ;
Gagel, Robert ;
Smith, Sean ;
Edwards, Beatrice J. ;
Frank, Elizabeth ;
Lyman, Gary H. ;
Smith, Matthew R. ;
Mhaskar, Rahul ;
Henderson, Tara ;
Neuner, Joan .
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31) :2916-+